Literature DB >> 34047244

Effectiveness, safety and efficacy of INTELLiVENT-adaptive support ventilation, a closed-loop ventilation mode for use in ICU patients - a systematic review.

M Botta1, E F E Wenstedt2, A M Tsonas1, L A Buiteman-Kruizinga1,3, D M P van Meenen1, H H M Korsten2,4, J Horn1,5, F Paulus1,6, A G J H Bindels2, M J Schultz1,7,8, A J R De Bie2,4.   

Abstract

Introduction: INTELLiVENT-Adaptive Support Ventilation (INTELLiVENT-ASV), an advanced closed-loop ventilation mode for use in intensive care unit (ICU) patients, is equipped with algorithms that automatically adjust settings on the basis of physiologic signals and patient's activity. Here we describe its effectiveness, safety, and efficacy in various types of ICU patients.Areas covered: A systematic search conducted in MEDLINE, EMBASE, the Cochrane Central register of Controlled Trials (CENTRAL), and in Google Scholar identified 10 randomized clinical trials.Expert opinion: Studies suggest INTELLiVENT-ASV to be an effective automated mode with regard to the titrations of tidal volume, airway pressure, and oxygen. INTELLiVENT-ASV is as safe as conventional modes. However, thus far studies have not shown INTELLiVENT-ASV to be superior to conventional modes with regard to duration of ventilation and other patient-centered outcomes. Future studies are needed to test its efficacy.

Entities:  

Keywords:  Artificial ventilation; INTELLiVENT–ASV; automated ventilation; closed–loop ventilation; effectiveness; efficacy; intensive care unit; invasive ventilation; protective ventilation; safety

Year:  2021        PMID: 34047244     DOI: 10.1080/17476348.2021.1933450

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  2 in total

1.  Automation to improve lung protection.

Authors:  Laura A Buiteman-Kruizinga; Ary Serpa Neto; Marcus J Schultz
Journal:  Intensive Care Med       Date:  2022-05-20       Impact factor: 41.787

2.  Effect of Automated Closed-loop ventilation versus convenTional VEntilation on duration and quality of ventilation in critically ill patients (ACTiVE) - study protocol of a randomized clinical trial.

Authors:  Michela Botta; Anissa M Tsonas; Jante S Sinnige; Ashley J R De Bie; Alexander J G H Bindels; Lorenzo Ball; Denise Battaglini; Iole Brunetti; Laura A Buiteman-Kruizinga; Pim L J van der Heiden; Evert de Jonge; Francesco Mojoli; Chiara Robba; Abraham Schoe; Frederique Paulus; Paolo Pelosi; Ary Serpa Neto; Janneke Horn; Marcus J Schultz
Journal:  Trials       Date:  2022-04-23       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.